• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600LDS23J
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/04/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
As reported by the edwards (b)(6) affiliate, a 23mm sapien 3 transcatheter heart valve was implanted during a transfemoral tavr procedure.While the operator evaluated for pvl and location of the implanted valve, the commander delivery system was backed out from the annulus.When post-dilation was about to be executed, safari guidewire came out.Radifocus guidewire was inserted to cross the annulus and then the safari guidewire was re-inserted.Commander delivery system was advanced again to execute the post-dilation.Right after the post-dilation, hemodynamics became instable.It was revealed that the safari guidewire was not across the sapien 3 valve, it was located outside the valve.The balloon was crashing the valve in the shape of a crescent moon.The percutaneous cardiopulmonary support (pcps) was implemented for stable hemodynamics and new 23mm sapien 3 valve was implanted.The patient became stable.The deformed first valve was moved to descending aorta and fixed with the stent graft.The procedure was closed.
 
Manufacturer Narrative
Added h.6 type of investigation and investigation findings.Corrected h.6 investigation conclusions.The device was not returned for evaluation.A device history review (dhr) was performed and did not reveal any manufacturing non-conformance issues that would have contributed to the complaint event.A lot history review was performed and revealed no other complaints relating to these events.As no device was returned and there is no evidence to support a manufacturing/design defect potentially contributed to the complaint, a manufacturing mitigation review is not required.The ifu, device preparation manual, and device procedural manual were reviewed.Factors that make it difficult to cross include: heavy calcification, wire bias into commissure, horizontal aorta, tortuous thoracic aorta, flex catheter kinked, and inadequate bav.If difficulty crossing is experienced, make sure the wire is correctly extended at the apex.Pull tension on the wire or reposition.Add some distal flex or remove some partial flex.Pull the system back and re-advance.Pull back flex catheter so it is off the balloon during deployment.Unlock the balloon lock.Slowly move back flex catheter (handle) while maintaining position of balloon catheter.Position flex tip in the middle of the triple marker.Lock the balloon lock.Placing flex tip on the middle of the triple marker will enable fine adjustment in either direction during thv positioning.Positioning flex tip on the triple marker prior to thv deployment will help maintain stability while ensuring unobstructed inflation during deployment.Partially unflexing may help when pulling back the flex catheter.Use the distal flex to position the thv coaxial.Slowly rotate the flex wheel away from you to help adjust the thv coaxial within the native valve.Wire manipulation or slight rotation of the delivery system may help.Unlock the balloon lock.Position thv with bottom of center marker at base of cusps.The inflow of the sapien 3 valve will be further in the ventricle when positioned prior to thv deployment.Use the center marker to help aid in thv positioning, but not as a reference during thv deployment (center marker on delivery system not thv).A coplanar view is critical for correctly positioning and deploying the thv.To reference the center marker properly, ensure crimped thv is exactly between the valve alignment markers.Review positioning and thv heights with the echocardiographer prior to the case.For optimal results place the entire center marker within the initial center marker zone.Anatomy (stj, calcification, coronaries, etc.), % area sizing, thv size and foreshortening/inflation volume should also be considered when positioning thv.Use the fine adjustment wheel to control fine positioning of the thv.Ensure the flex tip is pulled back to the middle of the triple marker.Ensure the balloon lock is locked.Turn the fine adjustment wheel to finely control the thv position in either direction.Release stored tension prior to thv deployment.Thv may lock into the calcium when positioning creating stored tension in the delivery system.Release delivery system tension prior to deployment by ensuring thv is coaxial within annulus on final position.No ifu/training deficiencies were identified.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.Since no product non-conformance was confirmed, a product risk assessment escalation is not required.Since no edwards defects were identified, no corrective/preventative actions are required.The cross difficulty and interaction with the pre-existing implantable device were unable to be confirmed as the complaint device and /or applicable imagery were not returned.Due to unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance was unable to be determined.A review of dhr, and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint.A review of the ifu and training manuals revealed no deficiencies.As reported, ''when the post-dilation was about to be executed, safari guidewire came out.Radifocus guidewire was inserted to cross the annulus and then the safari guidewire was re-inserted'' and ''it was revealed that the safari guidewire was not crossed the sapien 3 valve and it was located outside the valve.Because of this, the balloon was crashing the valve in shape of crescent moon.'' when guidewire positioning was lost, it is likely the delivery system was crossed incorrectly due to poor visualization of guidewire placement.As a consequence of incorrect guidewire placement, the balloon did not expand within the valve but adjacent to it.Thus, leading to the reported negative interaction with pre-existing implantable device.Available information suggests procedural factors (guidewire positioning) contributed to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key13625687
MDR Text Key286506887
Report Number2015691-2022-04198
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103194869
UDI-Public(01)00690103194869(17)230720(10)63901235
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/20/2023
Device Model Number9600LDS23J
Device Lot Number63901235
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/05/2022
Date Device Manufactured07/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age89 YR
-
-